Evaluation of the National Anti-Drug Strategy

Outputs

Prevention Action Plan

Knowledge products, knowledge exchange mechanisms, national and community-based projects, consultations, collaborations and partnerships.

Treatment Action Plan

Projects for treatment system improvements, services and program enhancements, research and knowledge products, knowledge exchange mechanisms, consultations, collaborations and partnerships.

Enforcement Action Plan

Legislation, regulations, legal advice, intelligence, investigations, audits, charges, seizures and destructions, prosecutions, case preparation/supervision, case reviews, drug analysis, compliance inspections and reports, authorizations, forensic accounting analyses, research, training, recruitment, collaborations, and national and international coordination.

Immediate Outcomes

Prevention Action Plan

• Increased awareness and understanding of illicit drugs, prescription drug abuse (PDA) and their negative consequences.
• Enhanced supports for targeted at-risk populations.
• Enhanced knowledge in communities to address illicit drug use, PDA and their negative consequences.

Treatment Action Plan

• Enhanced capacity to plan/deliver a range of treatment services and programs to targeted populations.
• Improved collaboration on responses and knowledge of treatment issues.

Enforcement Action Plan

• Increased effectiveness of efforts related to drug enforcement, tax compliance and prosecution of illicit drug producers and distributors.
• Increased effectiveness in the gathering, analyzing/sharing intelligence and analyzing evidence.
• Increased awareness of illicit drug and precursor chemical issues for enforcement officials.
• Increased effectiveness in controlling and monitoring controlled substances and precursor chemicals.

Intermediate Outcomes

Prevention Action Plan

• Enhanced capacity among targeted populations to make informed decisions about illicit drugs.
• Strengthened community responses to illicit drug and PDA issues in targeted areas.
• Reduced risk-taking behaviours related to illicit drugs and PDA.

Treatment Action Plan

• Increased availability of and access to effective treatment services and programs for targeted populations in areas of need.
• Enhanced uptake of evidence-informed treatment practices.
• Improved treatment systems, programs and services to address illicit drug dependency and PDA in targeted populations in areas of need.
• Reduced risk-taking behaviours related to illicit drugs and PDA.

Enforcement Action Plan

• Disrupting criminal organizations/operations related to illicit drug production and distribution.
• Improved intelligence and evidence about illicit drugs.
• Improved intelligence and evidence about PDA.
• Increased safety in dismantling illicit drug operations (e.g., Marihuana Grow Operations, Clandestine Laboratories).
• Increased compliance and reduced risk of diversion of controlled substances, prescription drugs and precursor chemicals.
• Reduced health, safety and security risks associated with illicit drug production.

Long-term Outcomes

• Reduced demand for illicit drugs in targeted populations.
• Reduced negative health and social impacts and crime related to illicit drug use and PDA.
• Reduced supply of illicit drugs.
• Reduced PDA in Canada.

Ultimate Outcome

• Safer and Healthier Communities